Skip to main content

Table 2 Summary of general statistical patient data

From: Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

Number of Patients
Histology
 Biphasic 7
 Epithelioid 73
 Sarcomatoid 6
 Unknown 5
Age [Years]
 Minimum 34.57
 Median 64.86
 Mean 64.26
 Maximum 81.76
 Unknown 4
Time to death [month]
 Minimum 0.77
 Median 17.33
 Mean 21.69
 Maximum 81.73
 Unknown 4
Clinical outcome
 Alive 9
 Dead 78
 Unknown 4